Group 1 | Group 2 | |
---|---|---|
No of patients entered | 30 | 30 |
No of patients withdrawn (side effects or poor compliance) | 2 | 2 |
No of patients lost to follow up | 0 | 3 |
No of evaluable patients | 28 | 25 |
Response | ||
Complete response | 9 (32.1%) | 0 (0%) |
Partial response | 11 (39.2%) | 2 (8%) |
No response | 8 (28.5%) | 23 (92%) |
Mean area of the lesions (mm2) | ||
Before treatment (SD) | 13.1 (5.4) | 12.8 (4.7) |
After treatment (SD) | 6.9 (3.8) | 11.9 (4.4) |